Barry Ticho

Barry Ticho MD, PhD, serves as the Chief Medical Officer at Stoke Therapeutics and is an Advisory Board Member at Sania Therapeutics, as well as a Scientific Advisory Board Member at Cardior Pharmaceuticals. Barry Ticho is also a Founder and Board Member at Verve Therapeutics and previously held the position of Head of Development for Cardiovascular and Metabolic Diseases at Moderna Therapeutics. Barry Ticho's educational background includes a BA in Biology from Haverford College and medical training at Harvard Medical School.